Abstract:For infectious diseases, rapid and accurate identification of the pathogen is critical for effective management and treatment, but diagnosis remains challenging, particularly in resource-limited areas. Methods that accurately detect pathogen nucleic acids can provide robust, accurate, rapid, and ultrasensitive technologies for point-of-care diagnosis of pathogens, and thus yield information that is invaluable for disease management and treatment. Several technologies, mostly PCR-based, have been employed for pathogen detection; however, these require expensive reagents and equipment, and skilled personnel. CRISPR/Cas systems have been used for genome editing, based on their ability to accurately recognize and cleave specific DNA and RNA sequences. Moreover, following recognition of the target sequence, certain CRISPR/Cas systems including orthologues of Cas13, Cas12a, and Cas14 exhibit collateral nonspecific catalytic activities that can be employed for nucleic acid detection, for example by degradation of a labeled nucleic acid to produce a fluorescent signal. CRISPR/Cas systems are amenable to multiplexing, thereby enabling a single diagnostic test to identify multiple targets down to attomolar (10-18 mol/L) concentrations of target molecules. Developing devices that couple CRISPR/Cas with lateral flow systems may allow inexpensive, accurate, highly sensitive, in-field deployable diagnostics. These sensors have myriad applications, from human health to agriculture. In this review, we discuss the recent advances in the field of CRISPR-based biosensing technologies and highlight insights of their potential use in a myriad of applications.

Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application

CRISPR/Cas Biosensing Technology: From Lab Assays to Integrated Portable Devices towards Wearables

Point‐of‐Care Pathogen Detection with CRISPR‐based Programmable Nucleic Acid Binding Proteins

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

Challenges and perspectives of CRISPR-based technology for diagnostic applications

CRISPR Cas system: A strategic approach in detection of nucleic acids

CRISPR: The Frontier Technology of Next-Generation RNA Detection

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing

Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies

The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection

Crispr-cas based biosensing: A fast-expanding molecular diagnostic tool

Harnessing CRISPR/Cas Systems for DNA and RNA Detection: Principles, Techniques, and Challenges

CRISPR/Cas‐Powered Biosensing

Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects